HC Wainwright Reiterates Buy Rating on Biomea Fusion, Keeps $4 Target
HC Wainwright reiterated its Buy rating and $4.00 price target on Biomea Fusion. The target implies 217.5% upside from the Oct. 13 close of $1.26.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.